To explore the potential mechanisms mediating RPRML silencing in GC, germline and somatic genetic alterations were evaluated by sequencing a cohort of 36 patients with familial GC and retrieving data from 393 sporadic cases from the TCGA-STAD dataset [21,23]. The gene discussed is RPRML; the disease is gastric cancer.